Study of MGCD0103 Given Three Times Weekly in Patients With Relapsed and Refractory Lymphoma
Clinical trial NCT00359086 · COMPLETED
Trial details
- NCT number
- NCT00359086
- Sponsor
- Mirati Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2012-01-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.